Skip to main content
. 2020 Dec 30;13(1):86. doi: 10.3390/cancers13010086
ACT Adoptive cell therapy
TIL Tumor-Infiltrating Lymphocyte
TCR T-Cell Receptor
CAR Chimeric Antigen Receptor
hiPSC-CMs human-induced pluripotent stem cell-derived cardiomyocytes
CTLA-4 Cytotoxic T-lymphocyte-associated antigen 4
ASE American Society of Echocardiography
EACVI European Association of Cardiovascular Imaging
IRAEs Immune-related adverse events
IMARs Immune-related adverse reactions
ICI Immune checkpoint inhibitors
LVD Left ventricular dysfunction
HFpEF Heart failure with preserved ejection fraction
PD-1 Programmed cell death protein-1
PD-L1 Programmed death ligand-1